DIAVACS, INC.
LA JOLLA, CA · Founded 2013 · CIK 0001575240 · Biotech · Defunct
Microsphere vaccine formulation containing antisense oligonucleotides targeting dendritic cells to suppress autoimmunity
diavacs.com →- Grants
- $231K
- 1 award
- Sector median: 1
- Raised
- $850K
- 3 Form D · Mar 2015
- 139 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122013201420152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $53 | |
| Private capital raised | Form D · SEC | $90 | |
| Private capital raised | Form D · SEC | $849,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Antisense-Loaded Microsphere Therapy for Autoimmune Diseases | $231,153 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2766 | Florey Biosciences, Inc. | — | $1.4M |
| 2767 | JSK THERAPEUTICS INC. | — | $963K |
| 2768 | Wave Bye Inc. | — | $852K |
| 2769 | DIAVACS, INC. | — | $850K |
| 2770 | OCEANYX PHARMACEUTICALS, INC. | — | — |
| 2771 | Niche Biopharmaceuticals LLC | — | $525K |
| 2772 | LACERTA THERAPEUTICS, INC. | — | $500K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Daniel BradburyDirector · Executive Officer
- Alexander CasdinDirector
- James GavinDirector
- Haro HartounianDirector · Executive Officer
- Alan LewisDirector
- Edwin NaylorDirector
- Vern NorvielExecutive Officer
- Dietrich StephanDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.